Latest News
Liquidia Corporation
- StockWatch: Liquidia Rebounds After Settling Legal Wrangle with United Therapeutics
- Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure
- Settlement with United keeps Liquidia's Yutrepia on the market, but with narrower label
- Liquidia Settles With United Therapeutics; $320.4M Payments, PH-ILD Indication Removed
- United lands 'clear-cut win' as Liquidia agrees to $380M settlement in Tyvaso patent infringement saga
- Liquidia surges as United Therapeutics settlement removes key litigation risk
- Liquidia (NASDAQ:LQDA) CMO Rajeev Saggar disposes of $262,528 in stock
- Why is Liquidia stock plunging? Yutrepia patent case explained
- Why is Liquidia stock down 5% today? By Investing.com
- Why is Liquidia share price falling by nearly 50% today? US federal court ruling linked to lung drug Yutre
- Liquidia slumps after US court rules for United Therapeutics in patent fight
- Liquidia loses patent infringement case on two claims By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →